Effect of oral probiotics on clinical efficacy and intestinal flora in elderly severe pneumonia patients

被引:1
作者
Zhu, Yonglin [1 ]
Ma, Guannan [2 ,3 ]
Ren, Wei [1 ]
Hu, Zhenyu [1 ]
Zhou, Ling [1 ]
Zhang, Xin [1 ]
Zhao, Na [1 ]
Zhang, Mingding [1 ]
Yan, Lei [1 ]
Yu, Qian [2 ,3 ]
Liu, Xuetong [2 ,3 ]
Chen, Jichao [1 ,4 ]
机构
[1] Aerosp Ctr Hosp, Beijing, Peoples R China
[2] Key Lab Digital Technol Med Diagnost Zhejiang Prov, Hangzhou, Peoples R China
[3] Beijing DA Med Lab, Beijing, Peoples R China
[4] Aerosp Ctr Hosp, Resp Intens Care Unit, 15 Yuquan Rd, Beijing 100049, Peoples R China
关键词
elderly patients; gut microbiota; probiotics; severe pneumonia; GUT MICROBIOTA; HOST-DEFENSE; HOSPITALIZATION; BURDEN;
D O I
10.1097/MD.0000000000036320
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Complex microbial ecosystems in both gastrointestinal and respiratory systems have been found to have a significant impact on human health. Growing evidence has demonstrated that intestinal dysbiosis can increase vulnerability to pulmonary infections. However, changes in the composition and activity of the intestinal flora after probiotic supplementation may alter the disease state of the host. The effects of probiotics on the improvement of diseases, such as severe pneumonia (SP), in intensive care units (ICUs) remain controversial. We retrospectively included 88 patients diagnosed with severe pneumonia between April 2021 and June 2022. The patients were divided into 2 groups: a probiotic group (n = 40) and a control group (n = 48). In addition, changes in CRP, PCT, WBC, IL-6, Clostridium difficile toxin, and PSI pneumonia scores were assessed. Changes in the gut microbiome of the patients were assessed using amplicon sequencing. Compared to the control group, a significant reduction in the incidence of length of hospital stay was observed in the probiotic group, but there were no significant differences in the mortality rate, duration of fever, diarrhea, and constipation. After probiotic treatment, CRP, PCT, WBC, and PSI score were significantly lower than before, and better clinical efficacy was achieved in the probiotic group for the duration of antibiotic therapy. Gut microbiota analysis revealed that the abundance of opportunistic pathogens (e.g., Massilia) increased remarkably at the genus level in the control group, and a significant increase in Erysipelotrichaceae_ge was observed after probiotic intervention. The control group showed an increase in opportunistic pathogens (Citrobacter, Massilia) during the antibiotic treatment. Probiotics interventions inhibit the growth of opportunistic pathogens. In addition, we found that the population of butyrate-producing bacteria (e.g., Ruminococcaceae UCG-005) increased following probiotic treatment.
引用
收藏
页数:7
相关论文
共 29 条
  • [1] Gut-lung axis and dysbiosis in COVID-19
    Aktas, Busra
    Aslim, Belma
    [J]. TURKISH JOURNAL OF BIOLOGY, 2020, 44 (03) : 265 - 272
  • [2] Mortality and Prognostic Prediction in Very Elderly Patients With Severe Pneumonia
    Baek, Moon Seong
    Park, Sojung
    Choi, Jeong-Hee
    Kim, Cheol-Hong
    Hyun, In Gyu
    [J]. JOURNAL OF INTENSIVE CARE MEDICINE, 2020, 35 (12) : 1405 - 1410
  • [3] The Burden of Community-Acquired Pneumonia Requiring Admission to ICU in the United States
    Cavallazzi, Rodrigo
    Furmanek, Stephen
    Arnold, Forest W.
    Beavin, Leslie A.
    Wunderink, Richard G.
    Niederman, Michael S.
    Ramirez, Julio A.
    [J]. CHEST, 2020, 158 (03) : 1008 - 1016
  • [4] Probiotics for the Prevention of Ventilator-Associated Pneumonia: An Updated Systematic Review and Meta-Analysis of Randomised Controlled Trials
    Cheema, Huzaifa Ahmad
    Shahid, Abia
    Ayyan, Muhammad
    Mustafa, Biah
    Zahid, Afra
    Fatima, Maurish
    Ehsan, Muhammad
    Athar, Farwa
    Duric, Natalie
    Szakmany, Tamas
    [J]. NUTRIENTS, 2022, 14 (08)
  • [5] COMMENSAL MICROFLORA CONTRIBUTE TO HOST DEFENSE AGAINST ESCHERICHIA COLI PNEUMONIA THROUGH TOLL-LIKE RECEPTORS
    Chen, Lee-Wei
    Chen, Pei-Hsuan
    Hsu, Ching-Mei
    [J]. SHOCK, 2011, 36 (01): : 67 - 75
  • [6] Management of pneumonia in critically ill patients
    Cilloniz, Catia
    Torres, Antoni
    Niederman, Michael S.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 375 : e065871
  • [7] Analysis of the Lung Microbiome in the "Healthy" Smoker and in COPD
    Erb-Downward, John R.
    Thompson, Deborah L.
    Han, Meilan K.
    Freeman, Christine M.
    McCloskey, Lisa
    Schmidt, Lindsay A.
    Young, Vincent B.
    Toews, Galen B.
    Curtis, Jeffrey L.
    Sundaram, Baskaran
    Martinez, Fernando J.
    Huffnagle, Gary B.
    [J]. PLOS ONE, 2011, 6 (02):
  • [8] Disordered Microbial Communities in Asthmatic Airways
    Hilty, Markus
    Burke, Conor
    Pedro, Helder
    Cardenas, Paul
    Bush, Andy
    Bossley, Cara
    Davies, Jane
    Ervine, Aaron
    Poulter, Len
    Pachter, Lior
    Moffatt, Miriam F.
    Cookson, William O. C.
    [J]. PLOS ONE, 2010, 5 (01):
  • [9] Microbiota regulates immune defense against respiratory tract influenza A virus infection
    Ichinohe, Takeshi
    Pang, Iris K.
    Kumamoto, Yosuke
    Peaper, David R.
    Ho, John H.
    Murray, Thomas S.
    Iwasaki, Akiko
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (13) : 5354 - 5359
  • [10] Community-Acquired Pneumonia Requiring Hospitalization among US Adults
    Jain, S.
    Self, W. H.
    Wunderink, R. G.
    Fakhran, S.
    Balk, R.
    Bramley, A. M.
    Reed, C.
    Grijalva, C. G.
    Anderson, E. J.
    Courtney, D. M.
    Chappell, J. D.
    Qi, C.
    Hart, E. M.
    Carroll, F.
    Trabue, C.
    Donnelly, H. K.
    Williams, D. J.
    Zhu, Y.
    Arnold, S. R.
    Ampofo, K.
    Waterer, G. W.
    Levine, M.
    Lindstrom, S.
    Winchell, J. M.
    Katz, J. M.
    Erdman, D.
    Schneider, E.
    Hicks, L. A.
    McCullers, J. A.
    Pavia, A. T.
    Edwards, K. M.
    Finelli, L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (05) : 415 - 427